Frieberg Jacob B. 4
Accession 0001062993-23-019059
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:30 PM ET
Size
39.4 KB
Accession
0001062993-23-019059
Insider Transaction Report
- Award
Stock Option (Right to Buy)
2023-06-30$3.62/sh+2,414$8,739→ 2,414 totalExercise: $5.34From: 2023-06-30Exp: 2033-06-27→ Common Stock (2,414 underlying) - Award
Stock Option (Right to Buy)
2023-09-29$0.77/sh+11,291$8,694→ 11,291 totalExercise: $1.13From: 2023-09-29Exp: 2033-09-26→ Common Stock (11,291 underlying)
- 2,501
Stock Option (Right to Buy)
Exercise: $78.90Exp: 2029-03-30→ Common Stock (2,501 underlying) - 2,385
Stock Option (Right to Buy)
Exercise: $82.80Exp: 2029-06-29→ Common Stock (2,385 underlying) - 3,756
Stock Option (Right to Buy)
Exercise: $54.15Exp: 2030-06-28→ Common Stock (3,756 underlying) - 6,545
Stock Option (Right to Buy)
Exercise: $31.05Exp: 2030-12-29→ Common Stock (6,545 underlying) - 4,535
Stock Option (Right to Buy)
Exercise: $44.70Exp: 2031-03-31→ Common Stock (4,535 underlying) - 28,586
Stock Option (Right to Buy)
Exercise: $32.25→ Common Stock (28,586 underlying) - 4,804
Stock Option (Right to Buy)
Exercise: $42.00Exp: 2031-06-28→ Common Stock (4,804 underlying) - 6,301(indirect: By Benbow Estates, Ltd.)
Common Stock
- 7,718
Stock Option (Right to Buy)
Exercise: $116.70→ Common Stock (7,718 underlying) - 1,856
Stock Option (Right to Buy)
Exercise: $107.55Exp: 2029-09-27→ Common Stock (1,856 underlying) - 4,235
Common Stock
- 12,870(indirect: By Gee Eff Services Limited)
Common Stock
- 6,396
Stock Option (Right to Buy)
Exercise: $204.00Exp: 2027-09-15→ Common Stock (6,396 underlying) - 2,737
Stock Option (Right to Buy)
Exercise: $72.75Exp: 2029-12-28→ Common Stock (2,737 underlying) - 3,336
Stock Option (Right to Buy)
Exercise: $60.00Exp: 2030-03-29→ Common Stock (3,336 underlying) - 15,679
Stock Option (Right to Buy)
Exercise: $59.25→ Common Stock (15,679 underlying) - 7,626
Stock Option (Right to Buy)
Exercise: $26.70Exp: 2030-09-28→ Common Stock (7,626 underlying) - 12,856
Stock Option (Right to Buy)
Exercise: $15.60Exp: 2031-12-29→ Common Stock (12,856 underlying) - 6,233
Stock Option (Right to Buy)
Exercise: $32.40Exp: 2031-09-28→ Common Stock (6,233 underlying) - 10,032
Stock Option (Right to Buy)
Exercise: $19.80Exp: 2032-03-28→ Common Stock (10,032 underlying) - 53,254
Stock Option (Right to Buy)
Exercise: $16.80→ Common Stock (53,254 underlying) - 12,064
Stock Option (Right to Buy)
Exercise: $16.20Exp: 2032-06-27→ Common Stock (12,064 underlying) - 26,260
Stock Option (Right to Buy)
Exercise: $7.43Exp: 2032-09-27→ Common Stock (26,260 underlying) - 19,852
Stock Option (Right to Buy)
Exercise: $9.68Exp: 2032-12-28→ Common Stock (19,852 underlying) - 32,107
Stock Option (Right to Buy)
Exercise: $5.99Exp: 2033-03-28→ Common Stock (32,107 underlying) - 143,848
Stock Option (Right to Buy)
Exercise: $6.15From: 2024-05-11→ Common Stock (143,848 underlying)
Footnotes (10)
- [F1]Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F10]Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2023. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.
- [F2]Mr. Frieberg is the sole owner and President of Gee Eff Services Limited.
- [F3]Exercisable in full as of the date of this report.
- [F4]This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
- [F5]This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
- [F6]This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
- [F7]This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
- [F8]This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.
- [F9]Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the second quarter of 2023. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.
Issuer
VACCINEX, INC.
CIK 0001205922
Related Parties
1- filerCIK 0001748346
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 4:30 PM ET
- Size
- 39.4 KB